Asymmetric Dimethylarginine is Associated with High-sensitivity C-reactive Protein and Early Carotid Atherosclerosis in Women with Previous Gestational Diabetes Mellitus

Overview

Journal Endocrine

Specialty Endocrinology

Date 2014 Jun 26

PMID 24962795

Citations 4

Authors

Wei Xia

Dajiang Li

Chunquan Zhang

Li Xu

Wenliang Xu

Yibing Shao

Affiliations

Soon will be listed here.

Abstract

Asymmetric dimethylarginine (ADMA) is increased in subjects with previous gestational diabetes mellitus (GDM). The aim of this study was to investigate the relationship between serum ADMA levels and early carotid atherosclerosis in women with history of GDM. A total of 42 normoglycemic women with previous GDM and 42 age-matched healthy controls were enrolled. Serum levels of ADMA, lipids, insulin, fasting and 2-h glucose following 75-g oral glucose tolerance test, and high sensitivity C-reactive protein (hsCRP) were measured. Carotid atherosclerosis was evaluated by ultrasonographically determined intima-media thickness (IMT). Serum ADMA and hsCRP were higher in women with previous GDM compared to the healthy controls (0.72 ± 0.16 vs. 0.41 ± 0.15 μmol/L, p < 0.001; 1.81 ± 0.32 vs. 1.05 ± 0.26 mg/L, p < 0.001; respectively). Carotid IMT was also increased in the previous GDM group (0.77 ± 0.14 vs. 0.52 ± 0.13 mm, p < 0.001). In women with previous GDM, ADMA was positively correlated with hsCRP (r = 41, p < 0.001) and carotid IMT (r = 0.38, p < 0.001). Multiple linear regression analysis revealed that ADMA was a significant predictor for elevated carotid IMT in subjects with previous GDM after adjusting for traditional risk factors (β = 0.26, p = 0.017). Our data demonstrated that serum ADMA was associated with hsCRP and carotid IMT in normoglycemic women with previous GDM.

Citing Articles

Asymmetric dimethylarginine and gestational diabetes mellitus: a systematic review and meta-analysis.

Tiong P, Kosmider L, Lassi Z, Arstall M, Andraweera P Endocrine. 2022; 80(2):283-291.

PMID: 36449126 DOI: 10.1007/s12020-022-03260-z.

Association Between Neutrophil-Lymphocyte Ratio and Gestational Diabetes-A Systematic Review and Meta-Analysis.

Pace N, Vassallo J J Endocr Soc. 2021; 5(7):bvab051.

PMID: 34095691 PMC: 8169042. DOI: 10.1210/jendso/bvab051.

Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios: are they useful for predicting gestational diabetes mellitus during pregnancy?.

Sargin M, Yassa M, Taymur B, Celik A, Ergun E, Tug N Ther Clin Risk Manag. 2016; 12:657-65.

PMID: 27217758 PMC: 4853164. DOI: 10.2147/TCRM.S104247.

Asymmetric dimethylarginine, a biomarker of cardiovascular complications in diabetes mellitus.

Konya H, Miuchi M, Satani K, Matsutani S, Yano Y, Tsunoda T World J Exp Med. 2015; 5(2):110-9.

PMID: 25992325 PMC: 4436934. DOI: 10.5493/wjem.v5.i2.110.

References

Heitritter S, Solomon C, Mitchell G, Skali-Ounis N, Seely E . Subclinical inflammation and vascular dysfunction in women with previous gestational diabetes mellitus. J Clin Endocrinol Metab. 2005; 90(7):3983-8. DOI: 10.1210/jc.2004-2494. View

Smirnova I, Kajstura M, Sawamura T, Goligorsky M . Asymmetric dimethylarginine upregulates LOX-1 in activated macrophages: role in foam cell formation. Am J Physiol Heart Circ Physiol. 2004; 287(2):H782-90. DOI: 10.1152/ajpheart.00822.2003. View

Boger R . Association of asymmetric dimethylarginine and endothelial dysfunction. Clin Chem Lab Med. 2003; 41(11):1467-72. DOI: 10.1515/CCLM.2003.225. View

Telejko B, Zonenberg A, Kuzmicki M, Modzelewska A, Niedziolko-Bagniuk K, Ponurkiewicz A . Circulating asymmetric dimethylarginine, endothelin-1 and cell adhesion molecules in women with gestational diabetes. Acta Diabetol. 2009; 46(4):303-8. DOI: 10.1007/s00592-008-0088-x. View

Alberti K, Zimmet P . Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998; 15(7):539-53. DOI: 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S. View

Fakhrzadeh H, Alatab S, Sharifi F, Mirarefein M, Badamchizadeh Z, Ghaderpanahi M . Carotid intima media thickness, brachial flow mediated dilation and previous history of gestational diabetes mellitus. J Obstet Gynaecol Res. 2012; 38(8):1057-63. DOI: 10.1111/j.1447-0756.2011.01829.x. View

Pleiner J, Mittermayer F, Langenberger H, Winzer C, Schaller G, Pacini G . Impaired vascular nitric oxide bioactivity in women with previous gestational diabetes. Wien Klin Wochenschr. 2007; 119(15-16):483-9. DOI: 10.1007/s00508-007-0838-8. View

Di Cianni G, Lencioni C, Volpe L, Ghio A, Cuccuru I, Pellegrini G . C-reactive protein and metabolic syndrome in women with previous gestational diabetes. Diabetes Metab Res Rev. 2006; 23(2):135-40. DOI: 10.1002/dmrr.661. View

Xia W, Shao Y, Wang Y, Wang X, Chi Y . Asymmetric dimethylarginine and carotid atherosclerosis in Type 2 diabetes mellitus. J Endocrinol Invest. 2012; 35(9):824-7. DOI: 10.1007/BF03347101. View

10.

Tarim E, Yigit F, Kilicdag E, Bagis T, Demircan S, Simsek E . Early onset of subclinical atherosclerosis in women with gestational diabetes mellitus. Ultrasound Obstet Gynecol. 2006; 27(2):177-82. DOI: 10.1002/uog.2687. View

11.

Kul M, Demirkaya E, Ipcioglu O, Karadeniz R, Tunc T, Vurucu S . Perinatal risk factors affecting the maternal and fetal asymmetric dimethylarginine levels. Turk J Pediatr. 2009; 51(2):141-5. View

12.

Juonala M, Viikari J, Alfthan G, Marniemi J, Kahonen M, Taittonen L . Brachial artery flow-mediated dilation and asymmetrical dimethylarginine in the cardiovascular risk in young Finns study. Circulation. 2007; 116(12):1367-73. DOI: 10.1161/CIRCULATIONAHA.107.690016. View

13.

Bo S, Signorile A, Menato G, Gambino R, Bardelli C, Gallo M . C-reactive protein and tumor necrosis factor-alpha in gestational hyperglycemia. J Endocrinol Invest. 2005; 28(9):779-86. DOI: 10.1007/BF03347566. View

14.

Anastasiou E, Lekakis J, Alevizaki M, Papamichael C, MEGAS J, Souvatzoglou A . Impaired endothelium-dependent vasodilatation in women with previous gestational diabetes. Diabetes Care. 1998; 21(12):2111-5. DOI: 10.2337/diacare.21.12.2111. View

15.

Napoli C, de Nigris F, Williams-Ignarro S, Pignalosa O, Sica V, Ignarro L . Nitric oxide and atherosclerosis: an update. Nitric Oxide. 2006; 15(4):265-79. DOI: 10.1016/j.niox.2006.03.011. View

16.

Kondo K, Kitagawa K, Nagai Y, Yamagami H, Hashimoto H, Hougaku H . Associations of soluble intercellular adhesion molecule-1 with carotid atherosclerosis progression. Atherosclerosis. 2005; 179(1):155-60. DOI: 10.1016/j.atherosclerosis.2004.09.018. View

17.

Davenport M, Goswami R, Shoemaker J, Mottola M . Influence of hyperglycemia during and after pregnancy on postpartum vascular function. Am J Physiol Regul Integr Comp Physiol. 2011; 302(6):R768-75. DOI: 10.1152/ajpregu.00115.2011. View

18.

Teerlink T, Nijveldt R, de Jong S, van Leeuwen P . Determination of arginine, asymmetric dimethylarginine, and symmetric dimethylarginine in human plasma and other biological samples by high-performance liquid chromatography. Anal Biochem. 2002; 303(2):131-7. DOI: 10.1006/abio.2001.5575. View

19.

Freire C, Barbosa F, de Almeida M, Miranda P, Barbosa M, Nogueira A . Previous gestational diabetes is independently associated with increased carotid intima-media thickness, similarly to metabolic syndrome - a case control study. Cardiovasc Diabetol. 2012; 11:59. PMC: 3403942. DOI: 10.1186/1475-2840-11-59. View

20.

Gumus I, Kargili A, Kaygusuz I, Derbent A, Karakurt F, Kasapoglu B . The association between serum asymmetric dimethyl arginine levels and a history of gestational diabetes among healthy women. Blood Coagul Fibrinolysis. 2012; 23(5):391-5. DOI: 10.1097/MBC.0b013e3283468acc. View